Dogs with intrahepatic portal hypertension of congenital cause have distinct diagnostic findings compared to dogs with chronic hepatitis-related portal hypertension

Objective: To compare signalment, laboratory, and imaging findings in dogs with intrahepatic portal hypertension (PH) secondary to congenital hepatic disorders or chronic hepatitis (idiopathic or copper associated). Methods: This was a multi-institutional retrospective study (January 1, 2013, to August 25, 2024). Dogs were included if they had clinical evidence of PH (multiple portosystemic shunts, peritoneal effusion, or both) and evidence of liver dysfunction. Dogs were classified as having congenital disease or chronic hepatitis causing PH based on blinded review of liver histopathology. Categorical variables were compared with the Fisher exact test. Continuous variables were compared via the Mann-Whitney U test; variables with P < .2 were included in a multivariable model. Results: 39 dogs met inclusion criteria (16 congenital and 23 chronic hepatitis). Dogs with chronic hepatitis were older and had higher serum bilirubin, ALP, and GGT concentrations; lower serum albumin concentrations; and lower platelet counts compared to dogs with congenital disease. Dogs with congenital hepatic disease had lower MCV. Age and MCV remained significant on multivariable analysis. Hepatic parenchymal heterogeneity on abdominal ultrasound was reported more frequently in dogs with chronic hepatitis. Conclusions: Liver biopsy remains the gold standard for diagnosing the cause of intrahepatic PH in dogs. However, age, specific clinicopathologic abnormalities, and hepatic ultrasonographic heterogeneity might help clinicians differentiate these conditions when histopathology is unavailable. Clinical Relevance: When liver biopsy is unavailable, clinicians evaluating dogs with PH might use age, MCV, albumin, platelet count, cholestatic enzyme activities, and hepatic ultrasonographic echotexture to prioritize congenital versus chronic hepatitis etiologies and guide prognostic counseling.

Authors

Institutions

Publication Details

Journal
Journal of the American Veterinary Medical Association
Published
2026-06-26
DOI
https://doi.org/10.2460/javma.26.03.0218
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dogs with intrahepatic portal hypertension of congenital cause have distinct diagnostic findings compared to dogs with chronic hepatitis-related portal hypertension

P. Albers, Sara A. Jablonski Wennogle, Mary Katherine Tolbert, Alison M. Lee et al.
Journal of the American Veterinary Medical Association
Liver Disease and Transplantation
article

Dogs with intrahepatic portal hypertension of congenital cause have distinct diagnostic findings compared to dogs with chronic hepatitis-related portal hypertension

P. Albers, Sara A. Jablonski Wennogle, Mary Katherine Tolbert, Alison M. Lee, Joao P. Cavasin, Tarini Ullal, Sarah Shropshire
article en

Abstract

Objective: To compare signalment, laboratory, and imaging findings in dogs with intrahepatic portal hypertension (PH) secondary to congenital hepatic disorders or chronic hepatitis (idiopathic or copper associated). Methods: This was a multi-institutional retrospective study (January 1, 2013, to August 25, 2024). Dogs were included if they had clinical evidence of PH (multiple portosystemic shunts, peritoneal effusion, or both) and evidence of liver dysfunction. Dogs were classified as having congenital disease or chronic hepatitis causing PH based on blinded review of liver histopathology. Categorical variables were compared with the Fisher exact test. Continuous variables were compared via the Mann-Whitney U test; variables with P < .2 were included in a multivariable model. Results: 39 dogs met inclusion criteria (16 congenital and 23 chronic hepatitis). Dogs with chronic hepatitis were older and had higher serum bilirubin, ALP, and GGT concentrations; lower serum albumin concentrations; and lower platelet counts compared to dogs with congenital disease. Dogs with congenital hepatic disease had lower MCV. Age and MCV remained significant on multivariable analysis. Hepatic parenchymal heterogeneity on abdominal ultrasound was reported more frequently in dogs with chronic hepatitis. Conclusions: Liver biopsy remains the gold standard for diagnosing the cause of intrahepatic PH in dogs. However, age, specific clinicopathologic abnormalities, and hepatic ultrasonographic heterogeneity might help clinicians differentiate these conditions when histopathology is unavailable. Clinical Relevance: When liver biopsy is unavailable, clinicians evaluating dogs with PH might use age, MCV, albumin, platelet count, cholestatic enzyme activities, and hepatic ultrasonographic echotexture to prioritize congenital versus chronic hepatitis etiologies and guide prognostic counseling.

Journal of the American Veterinary Medical Association
North Carolina State University (US), University of California, Davis (US), Michigan State University (US), Texas A&M University (US), Colorado State University (US), Mississippi State University (US)
Good health and well-being
Openalex Percentile: Top 8%
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.